1055. Incidence of intracranial bleeds in new users of low-dose aspirin a cohort study using the health improvement 1065. Predictive performance of the CHA2DS2 VASc rule in atrial fibrillation a …
1443. Balancing risk and benefit in venous thromboembolism trials concept for a bivariate endpoint trial design and analytic approach 1449. Hemophillia A and hemopholia B focus on arthropathy and …
2092. Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism systematic review and meta analysis 2103. Pulmonary embolism severity …
1683. Benefits and challenges of going abroad for research or clinical training 1685. Protamine (heparin) induced trombocytopenia 1696. Current and future perspectives in imaging of venous 171…
1905. Reflections on scientific collaboration between basic researches and clinicians 1908. Coagulation and non coagulation effects of thrombin 1917. Assesment of endothelial damage and cardiac i…
3. Inferior vena cava filters 13. Von willebrand factor and angiogenesis basic and applied issues 21. Association of stroke risk biomarkers with stroke symptomps the reason for geoghrafic and rac…
213. Inorganic polyphospate a key modulator of inflammation 219. Physiologic and pathophysiological roles of interaction between C type lectin like receptor 2 and podoplanin 230. The posthromboti…
405. so you want to publish your research in the journal of thrombosis and haemostasis 411. safety and efficacy of BAY 94-9027 a prolonged half life factor VIII 420. Bleeding risk of terminally i…
1557. Early postoperative bridging anticoagulation after mechanical heart valve replacement a systematic review and meta analysis 1568. Hypercoagulabiluty and the risk of myocardial infraction a…
1743. New paradigms in sepsis from prevention to protection of failing microcirculation 1757. Circulatory support devices fundamental aspects and clinical management of bleeding and thrombosis 17…